Astera Labs (NASDAQ:ALAB) Raised to “Buy” at Wall Street Zen

Astera Labs (NASDAQ:ALAB) was upgraded by Wall Street Zen from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Monday.

Several other equities analysts have also recently commented on the company. Evercore ISI increased their target price on Astera Labs from $104.00 to $215.00 and gave the company an “outperform” rating in a research note on Wednesday, August 6th. Northland Capmk downgraded shares of Astera Labs from a “strong-buy” rating to a “hold” rating in a report on Tuesday, July 22nd. Jefferies Financial Group raised their target price on Astera Labs from $95.00 to $130.00 and gave the company a “buy” rating in a research note on Tuesday, July 22nd. CICC Research assumed coverage on shares of Astera Labs in a research note on Friday, August 29th. They set an “outperform” rating and a $190.00 price objective on the stock. Finally, Cowen started coverage on shares of Astera Labs in a research note on Tuesday, September 30th. They set a “hold” rating on the stock. Twelve analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Astera Labs presently has a consensus rating of “Moderate Buy” and an average price target of $168.88.

Astera Labs Price Performance

Shares of ALAB stock opened at $179.31 on Monday. The firm has a market cap of $29.80 billion, a P/E ratio of 320.20, a PEG ratio of 4.70 and a beta of 1.37. Astera Labs has a 1-year low of $47.13 and a 1-year high of $262.90. The firm’s 50-day simple moving average is $196.79 and its 200-day simple moving average is $138.70.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, November 4th. The company reported $0.49 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.39 by $0.10. The firm had revenue of $230.58 million during the quarter, compared to the consensus estimate of $206.42 million. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The company’s revenue was up 103.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.23 EPS. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. Analysts expect that Astera Labs will post 0.34 earnings per share for the current fiscal year.

Insider Transactions at Astera Labs

In related news, Director Jack R. Lazar sold 22,500 shares of the business’s stock in a transaction that occurred on Wednesday, August 27th. The stock was sold at an average price of $178.42, for a total value of $4,014,450.00. Following the completion of the sale, the director directly owned 97,351 shares in the company, valued at approximately $17,369,365.42. The trade was a 18.77% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Jitendra Mohan sold 91,441 shares of Astera Labs stock in a transaction that occurred on Monday, August 18th. The stock was sold at an average price of $183.51, for a total value of $16,780,337.91. Following the completion of the transaction, the chief executive officer directly owned 2,170,877 shares in the company, valued at approximately $398,377,638.27. This represents a 4.04% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 1,092,997 shares of company stock worth $192,231,120. 12.50% of the stock is currently owned by company insiders.

Institutional Trading of Astera Labs

A number of institutional investors and hedge funds have recently modified their holdings of the company. Whittier Trust Co. bought a new stake in Astera Labs in the third quarter valued at $55,000. Atlantic Union Bankshares Corp boosted its stake in Astera Labs by 1,338.1% in the third quarter. Atlantic Union Bankshares Corp now owns 302 shares of the company’s stock worth $59,000 after purchasing an additional 281 shares in the last quarter. Oliver Lagore Vanvalin Investment Group acquired a new position in Astera Labs in the second quarter worth $29,000. Grove Bank & Trust acquired a new position in Astera Labs in the third quarter worth $68,000. Finally, Bernard Wealth Management Corp. acquired a new position in Astera Labs in the second quarter worth $36,000. 60.47% of the stock is currently owned by institutional investors.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.